In this episode of What's Up Wednesday, we review the article: Pharmacotherapies for Post-Bariatric Weight Regain: Real World Comparative Outcomes by Gazda et al. published in Obesity (Silver Spring) May 2021.This was retrospective analysis of 207 individuals at one center treated for post-bariatric surgery weight regain between 2014 to 2019 (Of note: this was prior to the availability of semaglutide 2.4 mg or tirzepatide). They compared the percent body weight loss between patients receiving either ILM (intensive lifestyle modification) alone, to those receiving  non-GLP-1 pharmacotherapy plus ILM,  to those receiving a GLP-1 agonist plus ILM.Listen in to hear the outcomes and to learn how to apply this latest science to your clinical practice! The full study can be found HERESupport the showThe Gaining Health Podcast will release a new episode every Wednesday, alternating between interviews with experts and "What's Up Wednesday" scientific updates.For a roadmap for developing an obesity program, editable forms and templates, patient education materials, and more, check out Gaining Health If you are loving this podcast, please consider supporting us on Patreon